CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 3 filers reported holding CTI BIOPHARMA CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $25,276 | -33.7% | 6,018 | -5.1% | 0.00% | – |
| Q4 2022 | $38,127 | -92.5% | 6,344 | -92.7% | 0.00% | – |
| Q3 2022 | $507,000 | – | 87,068 | +124282.9% | 0.00% | – |
| Q2 2022 | $0 | – | 70 | +311.8% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 17 | -100.0% | 0.00% | – |
| Q3 2018 | $2,051,000 | -70.6% | 949,700 | -32.2% | 0.00% | -100.0% |
| Q2 2018 | $6,972,000 | +27.7% | 1,400,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $5,460,000 | – | 1,400,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,068,191 | $4,719,000 | 9.14% |
| CAXTON CORP | 619,460 | $719,000 | 0.76% |
| BVF INC/IL | 6,929,690 | $8,038,000 | 0.50% |
| NEA Management Company, LLC | 7,140,450 | $8,283,000 | 0.33% |
| Orbimed Advisors | 9,520,600 | $11,044,000 | 0.16% |
| Renaissance Technologies | 2,103,792 | $2,440,000 | 0.00% |
| Paloma Partners Management Co | 30,289 | $35,000 | 0.00% |
| WEDBUSH SECURITIES INC | 12,600 | $15,000 | 0.00% |
| HRT FINANCIAL LP | 19,710 | $22,000 | 0.00% |
| FIRST MANHATTAN CO. LLC. | 33 | $0 | 0.00% |